Enlaza Therapeutics
PrivateLast Round
Strategic
Sep 2, 2025
Total Funding Raised
$161M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Enlaza Therapeutics is a biotechnology company that develops covalent protein therapeutics using its proprietary War-Lock platform to create highly selective biologic drugs for cancer and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enlaza Therapeutics Comparables
Compare Enlaza Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Matchpoint Therapeutics | 78% | |
| BridGene Biosciences | 74% | |
| Nexo Therapeutics | 73% | |
Enlaza Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Sep 2, 2025 | ||||
| Series A | Apr 30, 2024 | ||||
| Seed | Dec 15, 2022 |
Enlaza Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| A. M. Pappas & Associates | Series A |
| J.P. Morgan Private Capital | Series A |
| Frazier Life Sciences | Seed, Series A |
| Avalon Ventures | Series A, Seed |
| Amgen Ventures | Series A |
| Samantha | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 100% MoM, reaching 1.9K.
- Sep 2, 2025
$15M raised in early funding.
Enlaza Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Enlaza Therapeutics's valuation, stock price, and market status.